Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Align Technology (NASDAQ:ALGN...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Over the past six months, Envista’s shares (currently trading at $27.36) have posted a disappointing 7.6% loss, well below the S&P 500’s 10.5% gain. This may...
Envista’s second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management point...
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Envista (NYSE:NVST) reported second-quarter 2026 sales of $731 million, supported by 5% core revenue growth and contributions from foreign exchange and acquisitions that lifted total revenue growth to just over 7%.
President and Chief Executive Officer Paul Keel said the company delivered balanced
Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q2 CY2026, with sales up 7.1% year on year to $730.5 million. ...
Dental products company Envista Holdings (NYSE:NVST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.1% year on year ...
Dental products company Envista Holdings (NYSE:NVST) will be announcing earnings results this Wednesday after market hours. Here’s what to look for. Envista ...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Let’s dig into the relative performance of Envista (NYSE:NVST) and its peers as we unravel the now-completed Q1 dental equipment & technology earnings season...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloade...
Envista (NYSE:NVST) reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
On the company’s first-quarter earnings call, President and CEO Paul Keel said En
